Marinomed Biotech AG (VIE: MARI)
Austria
· Delayed Price · Currency is EUR 15.60
-0.50 (-3.11%)
Dec 20, 2024, 5:35 PM CET
Marinomed Biotech AG Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -6.87 | -6.79 | -6.4 | -5.89 | -6.01 | -7.22 | Upgrade
|
| Depreciation & Amortization | 0.41 | 0.41 | 0.4 | 0.38 | 0.23 | 0.16 | Upgrade
|
| Other Amortization | 0.27 | 0.27 | 0.27 | 0.23 | 0.2 | 0.17 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0 | 0 | -0.01 | - | 0 | - | Upgrade
|
| Other Operating Activities | 0.74 | 0.85 | 0.99 | 1.23 | 0.23 | 0.98 | Upgrade
|
| Change in Accounts Receivable | 1 | 1 | 1.52 | -0.78 | -2.04 | -1.33 | Upgrade
|
| Change in Inventory | 0.55 | 0.55 | -0.53 | -0.1 | -0.83 | 0.02 | Upgrade
|
| Change in Accounts Payable | -0.82 | -0.82 | -1.45 | 0.85 | 1.34 | -0.87 | Upgrade
|
| Change in Other Net Operating Assets | 0 | 0 | 0.01 | -0.77 | 0 | 0.45 | Upgrade
|
| Operating Cash Flow | -4.72 | -4.53 | -5.2 | -4.87 | -6.88 | -7.64 | Upgrade
|
| Capital Expenditures | -0.13 | -0.13 | -0.23 | -0.92 | -3.96 | -2.34 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | 0.02 | - | - | - | Upgrade
|
| Investment in Securities | - | - | - | - | - | -0.04 | Upgrade
|
| Investing Cash Flow | -0.1 | -0.13 | -0.21 | -0.92 | -3.96 | -2.38 | Upgrade
|
| Long-Term Debt Issued | - | 0.62 | 8 | 2.4 | 8 | 4 | Upgrade
|
| Long-Term Debt Repaid | - | -1.55 | -0.22 | -0.32 | -0.29 | -4.28 | Upgrade
|
| Net Debt Issued (Repaid) | -0.93 | -0.93 | 7.78 | 2.08 | 7.71 | -0.28 | Upgrade
|
| Issuance of Common Stock | - | - | - | 0.3 | 0.31 | 22.43 | Upgrade
|
| Other Financing Activities | 0.58 | - | - | -0 | -0.01 | -1.83 | Upgrade
|
| Financing Cash Flow | -0.35 | -0.93 | 7.78 | 2.38 | 8.01 | 20.32 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | -0 | -0 | - | 0 | 0.03 | - | Upgrade
|
| Net Cash Flow | -5.17 | -5.59 | 2.37 | -3.4 | -2.81 | 10.3 | Upgrade
|
| Free Cash Flow | -4.85 | -4.66 | -5.43 | -5.79 | -10.85 | -9.98 | Upgrade
|
| Free Cash Flow Margin | -73.40% | -50.71% | -48.16% | -49.75% | -133.53% | -147.95% | Upgrade
|
| Free Cash Flow Per Share | - | -3.07 | -3.62 | -3.92 | -7.37 | -7.04 | Upgrade
|
| Cash Interest Paid | 0.77 | 0.77 | 0.45 | 0.36 | 0.21 | 0.38 | Upgrade
|
| Cash Income Tax Paid | - | - | - | - | - | 0 | Upgrade
|
| Levered Free Cash Flow | -4.49 | -4.14 | -5.17 | -5.56 | -9.54 | -7.15 | Upgrade
|
| Unlevered Free Cash Flow | -2.94 | -2.58 | -3.6 | -4.62 | -9.09 | -6.73 | Upgrade
|
| Change in Net Working Capital | -0.63 | -0.73 | 0.77 | 0.88 | 1.51 | 1.21 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.